Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“The addition of quinidine , a selective inhibitor of CYP2D6, along with triacetyloleandomycin and sulphaphenazole produced an additional decrease in the rate of NT formation in all but the PM liver, but did not completely eliminate the reaction.”
British journal of clinical pharmacology • 1997 | View Paper
“However, in contrast, coincubation with the P450 2C9 inhibitor sulfaphenazole (10 μM) or the P450 2D6 inhibitor quinidine (40 μM) led to a 1.9- and 1.6-fold increase in DPAB-SG production, respectively.”